SARcode Gets Series A

SARcode, a San Francisco-based biotechnology firm developing small molecule drugs for treating inflammatory disease, has raised a Series A round. The funding came as part of a licensing deal with South San Francisco-based Sunesis Pharmaceuticals last week. Amount of the Series A funding were not disclosed. More information »